Product Information
AZITHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2854 per ML under NDC 70710145802. Its NADAC has been published 413 times since Nov 7, 2018.
FDA first approved this application on Jul 31, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710145802
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211147FDA Approved
7/31/2018
TE Code
AB
On Market Since
8/6/2018
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has been published 413 times since Nov 7, 2018, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2854 per ML |
|---|---|
| All-time high | $0.7499 (Nov 14, 2018) |
| All-time low | $0.2722 (Nov 20, 2024) |
| 52-week high | $0.3401 |
| 52-week low | $0.2854 |
| Median price | $0.4522 |
| Average price | $0.4674 |
| Largest weekly change | -26.0% (Jul 17, 2024) |
| Weeks tracked | 413 |
| Tracking since | Nov 7, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Azithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 200 MG/5 ML SUSP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2854 per ML (NDC 70710145802), effective Sep 30, 2026.
How has the price of AZITHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has declined 61.9%. It has been tracked across 413 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 200 MG/5 ML SUSP?
Since Nov 7, 2018, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.2722 (Nov 20, 2024) to a high of $0.7499 (Nov 14, 2018), with a median of $0.4522 per ML.
Are there cheaper alternatives to AZITHROMYCIN 200 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 200 MG/5 ML SUSP, is $0.2046 per ML — about 28% below AZITHROMYCIN 200 MG/5 ML SUSP.
Who manufactures AZITHROMYCIN 200 MG/5 ML SUSP?
AZITHROMYCIN 200 MG/5 ML SUSP (NDC 70710145802) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.